HealthArs Technica
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The vaccine reportedly thwarted the cancer's return and spread.
Join the argument
House rules →Comments load as you scroll.